Carbohydrate‐Based Antiviral Vaccines
Authors:
- 28 October 2008
- book chapter
- Published by Wiley
- p. 167-193
Abstract
No abstract availableKeywords
This publication has 148 references indexed in Scilit:
- Targeting the carbohydrates on HIV-1: Interaction of oligomannose dendrons with human monoclonal antibody 2G12 and DC-SIGNProceedings of the National Academy of Sciences, 2008
- Mass spectrometric characterization of glycosylation of hepatitis C virus E2 envelope glycoprotein reveals extended microheterogeneity of N-glycansJournal of the American Society for Mass Spectrometry, 2008
- Fully Synthetic Carbohydrate HIV Antigens Designed on the Logic of the 2G12 AntibodyJournal of the American Chemical Society, 2007
- Protein Glycosylation, Conserved from Yeast to Man: A Model Organism Helps Elucidate Congenital Human DiseasesAngewandte Chemie International Edition, 2006
- N-Glycans in the gp120 V1/V2 domain of the HIV-1 strain NL4-3 are indispensable for viral infectivity and resistance against antibody neutralizationMedical Microbiology and Immunology, 2006
- Toward Fully Synthetic Carbohydrate-Based HIV Antigen Design: On the Critical Role of BivalencyJournal of the American Chemical Society, 2004
- Reactivity‐Based One‐Pot Synthesis of Oligomannoses: Defining Antigens Recognized by 2G12, a Broadly Neutralizing Anti‐HIV‐1 AntibodyAngewandte Chemie International Edition, 2004
- Loss of active neuroinvasiveness in attenuated strains of West Nile virus: pathogenicity in immunocompetent and SCID miceArchives of Virology, 1994
- Comparison of complete amino acid sequences and receptor-binding properties among 13 serotypes of hemagglutinins of influenza A virusesVirology, 1991
- Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 Å resolutionNature, 1981